Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease
DOI10.1057/PALGRAVE.JORS.2602468zbMATH Open1176.92025OpenAlexW2070874522MaRDI QIDQ3545654FDOQ3545654
Authors:
Publication date: 11 December 2008
Published in: The Journal of the Operational Research Society (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1057/palgrave.jors.2602468
Recommendations
- scientific article; zbMATH DE number 854843
- Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women
- The evaluation of disease prevention and treatment using simulation models
- Choice of modelling technique for evaluating health care interventions
- Comparing strategies to prevent stroke and ischemic heart disease in the Tunisian population: Markov modeling approach using a comprehensive sensitivity analysis algorithm
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Operations research and management science (90B99)
Cited In (5)
- How many AEDs in which region? An economic decision model for the Austrian red cross
- Title not available (Why is that?)
- Simulation analysis of coronary heart disease, congestive heart failure and end-stage renal disease economic burden
- Comparing strategies to prevent stroke and ischemic heart disease in the Tunisian population: Markov modeling approach using a comprehensive sensitivity analysis algorithm
- Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women
This page was built for publication: Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3545654)
